Terumo Heart

Terumo Heart Names Tom Gould and Mark Bullivant to Senior Management Positions in Left Ventricular Assist Device Market

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

ANN ARBOR, Michigan - Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that it has named Thomas (Tom) B.

MORE..

ANN ARBOR, Michigan - Terumo Heart Inc., a wholly owned subsidiary of Terumo Corporation, today announced reaching a critical milestone in the worldwide expansion of its DuraHeart(TM) Left-Ventricular Assist System (LVAS) as the 100th patient was treated by Latif Arusoglu, MD and Michiel Morshuis, MD, cardiothoracic surgeons at the Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University of Bochum in Bad Oeynhausen, Germany.

MORE..

Older News

ANN ARBOR, Michigan - Sustained Benefits for Patients Awaiting Transplantation The DuraHeart(TM) Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were eligible for transplantation.

MORE..